Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET/computed tomography in articular manifestation of rheumatoid arthritis.
Shamim SA, Arora G, Kumar N, Behera A, Hussain J, Gupta R, Kumar R, Bal C.
Nucl Med Commun. 2022 Apr 1;43(4):428-432. doi: 10.1097/MNM.0000000000001532.
PMID:35045550
Extraskeletal localization of 99mTc-labeled bone-seeking tracers in bone scintigraphy.
Arend SM, Pauwels EK, Arndt JW, Meinders AE.
Neth J Med. 1994 Oct;45(4):177-91.
PMID:7808581
Frequency of superscan on bone scintigraphy: A systematic review.
Letter to the editor concerning "Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?".
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement.
Quartuccio N, Panareo S, Urso L, Sturiale L, Siracusa M, Arnone A, Alongi P, Baldari S, Bartolomei M, Arnone G.
Nucl Med Commun. 2021 Feb 1;42(2):198-204. doi: 10.1097/MNM.0000000000001321.
PMID:33252511
[Bone scintigraphy with 99mTc-pyrophosphate].
Senda K, Imaeda T.
Rinsho Hoshasen. 1975 Apr;20(4):301-8.
PMID:167210
Clinical characteristics and prognosis of dialysis patients with metastatic calcification diagnosed by 99mTc-MDP bone scintigraphy.
Wang J, Xiao J, Wang D.
Sci Rep. 2025 Jan 2;15(1):472. doi: 10.1038/s41598-024-84633-4.
PMID:39747388
Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
Bombardieri E, Setti L, Kirienko M, Antunovic L, Guglielmo P, Ciocia G.